Document:

Exhibit
        10.17

       
CONFIDENTIAL
      SETTLEMENT AGREEMENT 

    AND
      GENERAL RELEASE 

    

    This
      CONFIDENTIAL SETTLEMENT AGREEMENT AND GENERAL RELEASE (the “Agreement”), is
      entered into as of this 21st
      day of
      December, 2007 by and among NanoSensors, Inc., a Nevada
      corporation
      (the “Company”), and Robert Coutu (the “Creditor”), with offices at
      __________________________________. The Company and Creditor may be referred
      to
      collectively as the“Parties”
      throughout this Agreement.

    

    WHEREAS,
      Creditor
      has claimed that the Company is indebted to it for certain amounts;
      and

    

    WHEREAS,
      the
      Creditor and Company desire to
      reach
      a full and final settlement of all claims
      that
      Creditor may have against Company without resort to litigation; and

    

    THEREFORE,
      IT IS STIPULATED AND AGREED
      among
      the Parties that in
      full
      and complete satisfaction of all claims among the Parties, the Parties agree
      as
      follows:

    

    1. Payment
      by Company to Creditor.
      The
      Company agrees to pay Creditor the sum of $2,500 (the “Payment”) as quickly as
      shall be practicable. This amount is payment to Creditor in full as a compromise
      of any and all amounts owed by the Company to the Creditor. 

    

    2. Release
      by Creditor.
      For and
      in consideration of the Payment, the Creditor, on behalf of itself and its
      assigns, heirs, beneficiaries, creditors, representatives, subsidiaries, parent
      companies, officers, employees, agents and affiliates (the “Releasing Parties”),
      hereby fully and finally releases, acquits and forever discharges the Company,
      and the officers, directors, partners, general partners, limited partners,
      managing directors, members, stockholders, trustees, shareholders,
      representatives, employees, principals, agents, affiliates, parents,
      subsidiaries, joint ventures, predecessors, successors, assigns, beneficiaries,
      heirs, executors, personal or legal representatives, insurers and attorneys
      of
      any of them (collectively, the “Released Parties”), from any and all actions,
      debts, claims, counterclaims, demands, liabilities, damages, causes of action,
      costs, expenses, accounts, covenants, contracts, agreements and compensation
      of
      every kind and nature whatsoever, past, present, or future, at law or in equity,
      whether known or unknown, which such Releasing Parties, or any of them, had,
      has, or may have had at any time in the past until and including the date of
      this Agreement against the Released Parties, or any of them, including but
      not
      limited to any services performed by the Creditor for the Company and any
      invoices or charges submitted by the Creditor to the Company. Creditor
      acknowledges and agrees that the release it gives to the Company hereunder
      applies to all claims for injuries, damages, or losses to its own person and
      property, real or personal, economic damages and/or economic injury or to those
      injuries, damages, or losses that are known or unknown, foreseen and unforeseen,
      patent or latent which it may have against the Company. The Creditor waives
      the
      application of California Civil Code §1542. Further, the Creditor agrees that
      all existing contracts between the Company and the Creditor are hereby
      terminated.

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    3. Waiver
      of California Civil Code §1542.
      The
      Creditor certifies that it has read the following provisions of California
      Civil
      Code §1542:

    

    A
      general
      release does not extend to claims which the creditor does not know or suspect
      to
      exist in his favor at the time of executing the release, which if known by
      him
      must have materially affected his settlement with the debtor.

    

    Creditor
      understands and acknowledges that the significance in consequence of this waiver
      of California Civil Code §1542 is that even if it should eventually suffer
      additional damages arising out of the facts referred to herein, it will not
      be
      able to make any claim for those damages. Furthermore, Creditor acknowledges
      that it consciously intends these consequences even as to claims for damages
      that may exist as of the date of this Agreement, but which it does not know
      exist, and which, if known, would materially affect its decision to execute
      this
      Agreement, regardless of whether its lack of knowledge as a result of ignorance,
      oversight, error, negligence, or any other cause.

    

    4. Attorney
      Representation.
      The
      Creditor warrants and represents in executing this Agreement it has had an
      opportunity to obtain legal advice from the attorney of its choice; and that
      the
      terms of this Agreement have been read and its consequences have been completely
      explained to it by that attorney and that it fully understands the terms of
      this
      Agreement. The Creditor further acknowledges and represents that, in executing
      this Agreement it is has not relied on the inducements, promises, or
      representations made by any party. Creditor is aware that it or its attorneys
      may hereafter discover facts different from or in addition to the facts that
      it
      now knows or believes to be true with respect to the subject matter of this
      Agreement or the other Party hereto, but that it is its intention to fully
      and
      finally release the Company and the other Released Parties to the full extent
      of
      the releases contained in this Agreement, and to otherwise agree to the other
      terms and conditions of this Agreement. 

    

    5. Covenant
      Not To Sue.
      The
      Creditor further agrees not to institute any litigation, lawsuit, claim, action
      or other proceeding, assert any right or claim for damages or loss or for any
      equitable relief that it may have against the Company or any Released Party
      with
      respect to any and all claims released under this Agreement. 

    

    6. No
      Reliance.
      The
      Creditor hereby represents and warrants that it has access to adequate
      information regarding the terms of this Agreement, the scope and effect of
      the
      releases set forth herein, and all other matters encompassed by this Agreement
      to make an informed, knowledgeable and independent decision with regard to
      entering into this Agreement. The Creditor further represents and warrants
      that
      it has not relied upon the Company, or the Released Parties in deciding to
      enter
      into this Agreement and has instead made its own independent analysis and
      decision to enter into this Agreement.

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    7. No
      Assignment.
      The
      Creditor represents and warrants that it is the sole and lawful owner of all
      rights, titles and interest in and to every claim and other matters which it
      releases herein, and that no other person, individual, or entity has received
      any assignment or other right of substitution or subrogation to any matters
      relating to or arising out of the claims against the Released Parties released
      herein. Creditor further represents, warrants, and agrees that no legal
      proceeding or other action, including an arbitration proceeding, has been filed
      in any forum arising out of, from, or in connection with any disputes or claims
      arising out of or related to the claims released in this Agreement.

     

    8. Sufficiency
      of Consideration.
      The
      Creditor acknowledges that the Payment provides good and sufficient
      consideration for every promise, duty, release, obligation, agreement and right
      contained in this Agreement.

     

    9.
       Confidentiality. The
      Creditor shall not directly or indirectly disclose or make any statement
      (written or oral) to any person, firm or entity not a party to this Agreement
      with respect to the matters covered by this Agreement, execution of this
      document, the settlement, the terms and conditions of the settlement,
      disclosures and representations made in this document, or anything else in
      connection with this matter except for any disclosure required to comply with
      any governmental rule, law, statute, regulatory requirement, arbitration or
      court proceeding. If Creditor receives a subpoena or order, which seeks to
      compel disclosure of this agreement, it shall afford the Company five (5) days
      notice to quash or limit such subpoena or order. 

    

    10. No
      Admission of Liability.
       The
      Parties acknowledge and agree that this Agreement is being executed in order
      to
      resolve and forever set at rest all the claims of whatever nature that Creditor
      may have against the Company, and that neither the Agreement or general releases
      set forth herein nor the underlying settlement constitute or are to be construed
      as an acknowledgment or admission of any liability whatsoever, any such
      liability being expressly denied.

    

    11. Multiple
      Counterparts.
      This
      Agreement may be executed in a number of identical counterparts, all of which
      shall constitute one agreement. A fully executed copy, including xerox or
      facsimile copies, together with any signatures thereon, shall be deemed an
      original for all purposes. 

    

    12. Severability.
      The
      provisions of this Agreement are severable, and if any part of it is found
      to be
      unenforceable, the surviving portions shall remain fully enforceable.

    

    13. General.
      This
      Agreement: (a) shall not be assignable by the Creditor except with the written
      consent of the Company; (b) shall be binding upon and shall inure to the benefit
      of, the parties hereto and their respective successors and assigns; (c) may
      not
      be amended or modified, nor may compliance with any condition or covenant set
      forth herein be waived, except by a writing duly and validly executed by the
      Company and the Creditor or, in the case of a waiver, the party waiving
      compliance, and no delay on the part of any party in exercising any right,
      power
      or privilege hereunder shall operate as a waiver thereof, nor shall any waiver
      on the part of any party of any such right, power or privilege, or any single
      or
      partial exercise of any such right, power or privilege, preclude any further
      exercise thereof or the exercise of any other such right, power or privilege;
      and (d) constitutes the entire agreement between the parties with respect to
      the
      subject matter hereof and supercedes all prior or contemporaneous agreements,
      understandings or communications.

      

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    14. Construction. The
      language of this Agreement shall be construed as a whole, according to its
      fair
      meaning, and not strictly for or against either of the Parties. For
      purposes of construction, this Agreement shall be deemed to have been drafted
      by
      all the Parties, and no ambiguity shall be resolved against any Party by virtue
      of his or her participation in the drafting of this agreement. Section headings
      have been inserted for convenience of reference only and are not intended to
      be
      a part of, or to affect, the meaning or interpretation of this
      Agreement.

    

    15.
       Governing
      Law.
      This
      Agreement shall be governed by and construed in accordance with the domestic
      laws of the State of California without giving effect to any choice or conflict
      of law provision or rule (whether of the State of California or any other
      jurisdiction) that would cause the application of the laws of any jurisdiction
      other than the State of California. The Parties (a) agree that any legal suit,
      action or proceeding arising out of or relating to this Agreement shall be
      instituted exclusively in United States District Court for the Northern District
      of California, (b) waives any objection which any Party may have now or
      hereafter to the venue of any such suit, action or proceeding, and (c)
      irrevocably consent to the jurisdiction of the United States District Court
      for
      the Northern District of California in any such suit, action or procedure.
      In
      the event of any suit action or proceeding arising out of or relating to this
      Agreement, the prevailing party shall be entitled to reasonable legal fees
      and
      related expenses as may be awarded by the court.

    

    16. Notices.
       All
      notices, requests, demands, claims, and other communications hereunder will
      be
      in writing. Any notice, request, demand, claim, or other communication hereunder
      shall be deemed duly given if (i) (and then three business days after) it is
      sent by registered or certified mail, return receipt requested, postage prepaid,
      or (ii) sent by overnight courier service, and addressed to the intended
      recipient as set forth below:

    

    
      	
              If
                to the Creditor:

               

              Robert
                Coutu

               

               

            	
              If
                to the Company:

               

              NanoSensors,
                Inc.

              1475
                Veterans Boulebard

              Redwood
                City, CA 94063

              Fax:
                (650) 618-1483

              Attn.:
                Josh Moser

            

    

    

    Any
      Party
      may send any notice, request, demand, claim, or other communication hereunder
      to
      the intended recipient at the address set forth above using any other means
      (including personal delivery, expedited courier, messenger service, fax or
      ordinary mail), but no such notice, request, demand, claim, or other
      communication shall be deemed to have been duly given unless and until it
      actually is received by the intended recipient. Any Party may change the address
      to which notices, requests, demands, claims, and other communications hereunder
      are to be delivered by giving the other Parties notice in the manner herein
      set
      forth.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    17. Due
      Execution.
       Each
      Party represents and warrants that its execution, delivery and performance
      of
      this Agreement and the consummation of the transactions contemplated hereby,
      including the release of claims by Creditor, is within each Party’s powers and
      that each Party has been duly authorized by all necessary corporate or other
      action

    

    IN
      WITNESS WHEREOF, the Parties have caused their duly authorized representatives
      to execute this Agreement as of the date first set forth above.

    

    
      	 	
              NANOSENSORS,
                INC.

            
	 	 	 
	 	
              By:
                

            	
              /s/
                Josh Moser 

            
	 	 	
              Name:
                Josh Moser

            
	 	 	
              Its
                Chief Financial Officer 

            
	 	 	 
	 	
              CREDITOR:

            
	 	 	 
	 	 	 
	 	
              By:
                

            	
              /s/
                Robert Coutu

            
	 	 	
              Name:
                Robert Coutu

            

    

    

    
      
        
        

      

      
        5EXHIBIT
      10.1

     

    SECURITIES
      PURCHASE AGREEMENT

     

    SECURITIES
      PURCHASE AGREEMENT
      (the
“Agreement”),
      dated
      as of February 25, 2008, by and among Agfeed Industries, Inc., a Nevada
      corporation, with headquarters located at 1095 Qing Lan Avenue, Economic and
      Technical Development Zone, Nan Chang City, Jiangxi Province (the ”Company”),
      and
      the investors listed on the Schedule of Buyers attached hereto (individually,
      a
“Buyer”
and
      collectively, the “Buyers”).

     

    WHEREAS:

     

    A. The
      Company and each Buyer is executing and delivering this Agreement in reliance
      upon the exemption from securities registration afforded by Section 4(2) of
      the
      Securities Act of 1933, as amended (the “1933
      Act”),
      and
      Rule 506 of Regulation D (“Regulation D”)
      as
      promulgated by the United States Securities and Exchange Commission (the
“SEC”)
      under
      the 1933 Act.

     

    B. The
      Company has authorized a new series of senior secured convertible notes of
      the
      Company, which notes shall be convertible into the Company’s common stock, $.001
      par value per share (the “Common
      Stock”),
      in
      accordance with the terms of such notes.

     

    C. Each
      Buyer wishes to purchase, and the Company wishes to sell, upon the terms and
      conditions stated in this Agreement, (i) that aggregate principal amount of
      notes, in substantially the form attached hereto as Exhibit
      A
      (as
      amended or modified from time to time, collectively, the “Notes”),
      set
      forth opposite such Buyer’s name in column (3) on the Schedule of Buyers (which
      aggregate amount for all Buyers shall be $18,000,000) (as converted,
      collectively, the “Conversion
      Shares”)
      and
      (ii) warrants, in substantially the form attached hereto as Exhibit
      B
      (the
“Warrants”),
      to
      acquire a number of additional shares of Common Stock determined as set forth
      in
      the Warrants (as exercised, collectively, the ”Warrant
      Shares”).

     

    D. Contemporaneously
      with the execution and delivery of this Agreement, the parties hereto are
      executing and delivering a Registration Rights Agreement, substantially in
      the
      form attached hereto as Exhibit
      C
      (as
      amended or modified from time to time, the “Registration
      Rights Agreement”),
      pursuant to which the Company has agreed to provide certain registration rights
      with respect to the Conversion Shares and the Warrant Shares under the 1933
      Act
      and the rules and regulations promulgated thereunder, and applicable state
      securities laws.

     

    E. The
      Notes, the Conversion Shares, the Warrants and the Warrant Shares collectively
      are referred to herein as the “Securities”.

     

    F. The
      Notes
      will rank senior to all outstanding and future indebtedness of the Company
      and
      its Subsidiaries other than as permitted hereunder.

     

    G. The
      proceeds from the sale of the Securities will be used for (i) general corporate
      purposes, (ii) to satisfy the remaining installments on the Company’s most
      recent hog farming acquisitions as they become due, and (iii) for acquisitions
      of complementary businesses, technologies and other assets.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    NOW,
      THEREFORE,
      the
      Company and each Buyer hereby agree as follows:

     

    1. PURCHASE
      AND SALE OF NOTES AND WARRANTS.

     

    (a) Purchase
      of Notes and Warrants.

     

    (i) Subject
      to the satisfaction (or waiver) of the conditions set forth in Sections 6 and
      7
      below, the Company shall issue and sell to each Buyer, and each Buyer severally,
      but not jointly, agrees to purchase from the Company on the Closing Date (as
      defined below), (x) a principal amount of Notes as is set forth opposite such
      Buyer’s name in column (3) on the Schedule of Buyers and (y) Warrants to acquire
      a number of Warrant Shares determined as is set forth in the Warrants (the
      “Closing”).

     

    (ii) Closing.
      The
      date and time of the Closing (the “Closing
      Date”)
      shall
      be the first business day following notification of satisfaction (or waiver)
      of
      the conditions to the Closing set forth in Sections 6 and 7 below at the offices
      of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP, 220 West
      42nd
      Street,
      New York, New York, 10036 (or such other place as mutually agreed upon by the
      parties hereto). By agreement of the parties hereto, the Closing may be
      alternatively accomplished by facsimile transmission to the respective offices
      of legal counsel for the parties of the requisite documents, duly executed
      where
      required, with originals to be delivered by overnight courier service on the
      next business day following the Closing Date.

     

    (iii) Purchase
      Price.
      The
      aggregate purchase price for the Notes and the Warrants to be purchased by
      each
      Buyer at the Closing (the “Purchase
      Price”)
      shall
      be the amount set forth opposite such Buyer’s name in column (4) of the Schedule
      of Buyers.

     

    (b) Form
      of Payment.
      On the
      Closing Date, (i) each Buyer shall pay its Purchase Price for the Notes and
      the
      Warrants to be issued and sold to such Buyer at the Closing, by wire transfer
      of
      immediately available funds in accordance with the Company’s written wire
      instructions, and (ii) the Company shall deliver to each Buyer (A) the
      Notes (in the principal amounts as such Buyer shall request) that such Buyer
      is
      then purchasing and (B) the Warrants (in the amounts as such Buyer shall
      request) such Buyer is purchasing, in each case duly executed on behalf of
      the
      Company and registered in the name of such Buyer or its designee.

     

    2. BUYER’S
      REPRESENTATIONS AND WARRANTIES.

     

    Each
      Buyer represents and warrants that: 

     

    (a) No
      Public Sale or Distribution.
      Such
      Buyer is (i) acquiring the Notes and the Warrants and (ii) upon conversion
      of
      the Notes and exercise of the Warrants (other than pursuant to a Cashless
      Exercise (as defined in the Warrants)) will acquire the Conversion Shares
      issuable upon conversion of the Notes and the Warrant Shares issuable upon
      exercise of the Warrants, as the case may be, in each case, for its own account
      and not with a view towards, or for resale in connection with, the public sale
      or distribution thereof, except pursuant to sales registered or exempted under
      the 1933 Act; provided,
      however, that by making the representations herein, such Buyer does not agree
      to
      hold any of the Securities for any minimum or other specific term and reserves
      the right to dispose of the Securities at any time in accordance with or
      pursuant to a registration statement or an exemption under the Securities Act
      of
      1933, as amended (the “1933
      Act”).
      Such
      Buyer does not presently have any agreement or understanding, directly or
      indirectly, with any Person to distribute any of the Securities.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (b) Accredited
      Investor/Qualified Institutional Buyer Status.
      Such
      Buyer is an “accredited investor” or a “qualified institutional buyer,” as such
      term is defined in Rule 501(a) of Regulation D or Rule
      144A
      under the Securities Act, respectively.

     

    (c) Reliance
      on Exemptions.
      Such
      Buyer understands that the Securities are being offered and sold to it in
      reliance on specific exemptions from the registration requirements of United
      States federal and state securities laws and that the Company is relying in
      part
      upon the truth and accuracy of, and such Buyer’s compliance with, the
      representations, warranties, agreements, acknowledgments and understandings
      of
      such Buyer set forth herein to determine the availability of such exemptions
      and
      the eligibility of such Buyer to acquire the Securities.

     

    (d) Information.
      Such
      Buyer and its advisors, if any, have been furnished with all materials relating
      to the business, finances and operations of the Company and materials relating
      to the offer and sale of the Securities that have been requested by such Buyer.
      Such Buyer and its advisors, if any, have been afforded the opportunity to
      ask
      questions of the Company. Neither such inquiries nor any other due diligence
      investigations conducted by such Buyer or its advisors, if any, or its
      representatives shall modify, amend or affect such Buyer’s right to rely on the
      Company’s representations and warranties contained herein. Such Buyer
      understands that its investment in the Securities involves a high degree of
      risk. Such Buyer has sought such accounting, legal and tax advice as it has
      considered necessary to make an informed investment decision with respect to
      its
      acquisition of the Securities.

     

    (e) No
      Governmental Review.
      Such
      Buyer understands that no United States federal or state agency or any other
      government or governmental agency has passed on or made any recommendation
      or
      endorsement of the Securities or the fairness or suitability of the investment
      in the Securities nor have such authorities passed upon or endorsed the merits
      of the offering of the Securities.

     

    (f) Transfer
      or Resale.
      Such
      Buyer understands that except as provided in the Registration Rights Agreement:
      (i) the Securities have not been and are not being registered under the 1933
      Act
      or any state securities laws, and may not be offered for sale, sold, assigned
      or
      transferred unless (A) subsequently registered thereunder, (B) such Buyer shall
      have delivered to the Company an opinion of counsel selected by the Buyer,
      in a
      form reasonably acceptable to the Company, to the effect that such Securities
      to
      be sold, assigned or transferred may be sold, assigned or transferred pursuant
      to an exemption from such registration, or (C) such Buyer provides the Company
      with reasonable assurance that such Securities can be sold, assigned or
      transferred pursuant to Rule 144 or Rule 144A promulgated under the 1933 Act,
      as
      amended, (or a successor rule thereto) (collectively, “Rule
      144”);
      (ii)
      any sale of the Securities made in reliance on Rule 144 may be made only in
      accordance with the terms of Rule 144 and further, if Rule 144 is not
      applicable, any resale of the Securities under circumstances in which the seller
      (or the Person (as defined in Section 3(s)) through whom the sale is made)
      may
      be deemed to be an underwriter (as that term is defined in the 1933 Act) may
      require compliance with some other exemption under the 1933 Act or the rules
      and
      regulations of the SEC thereunder; and (iii) neither the Company nor any
      other Person is under any obligation to register the Securities under the 1933
      Act or any state securities laws or to comply with the terms and conditions
      of
      any exemption thereunder.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (g) Legends.
      Such
      Buyer understands that the certificates or other instruments representing the
      Notes and Warrants and, until such time as the resale of the Conversion Shares
      and the Warrant Shares have been registered under the 1933 Act as contemplated
      by the Registration Rights Agreement, the stock certificates representing the
      Conversion Shares and the Warrant Shares, except as set forth below, shall
      bear
      any legend as required by the “blue sky” laws of any state and a restrictive
      legend in substantially the following form (and a stop-transfer order may be
      placed against transfer of such stock certificates):

     

    [NEITHER
      THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR
      THE
      SECURITIES INTO WHICH THESE SECURITIES ARE [CONVERTIBLE] [EXERCISABLE]
      HAVE
      BEEN][THE
      SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN]
      REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
      SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED
      OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR
      THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION
      OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A FORM REASONABLY
      ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT
      OR
      (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT.
      NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION
      WITH
      A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY
      THE
      SECURITIES.

     

    The
      legend set forth above shall be removed and the Company shall issue a
      certificate without such legend to the holder of the Securities upon which
      it is
      stamped, if, unless otherwise required by state securities laws, (i) such
      Securities are registered for resale under the 1933 Act, (ii) in connection
      with
      a sale, assignment or other transfer, such holder provides the Company with
      an
      opinion of counsel, in a generally acceptable form, to the effect that such
      sale, assignment or transfer of the Securities may be made without registration
      under the applicable requirements of the 1933 Act, or (iii) such holder provides
      the Company with reasonable assurance that the Securities can be sold, assigned
      or transferred pursuant to Rule 144 or Rule 144A.

     

    (h) Validity;
      Enforcement.
      This
      Agreement and the Registration Rights Agreement to which such Buyer is a party
      have been duly and validly authorized, executed and delivered on behalf of
      such
      Buyer and shall constitute the legal, valid and binding obligations of such
      Buyer enforceable against such Buyer in accordance with their respective terms,
      except as such enforceability may be limited by general principles of equity
      or
      applicable bankruptcy, insolvency, reorganization, moratorium, liquidation
      and
      other similar laws relating to, or affecting generally, the enforcement of
      applicable creditors’ rights and remedies.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (i) Residency.
      Such
      Buyer is a resident of that jurisdiction specified below its address on the
      signature page hereto.

     

    (j) Broker.
      The
      undersigned acknowledges and agrees that the Company intends to pay commissions
      to Deutsche Bank Securities Inc. of cash equal to eight and six-tenths percent
      (8.6%) of the gross proceeds received by the Company from the transactions
      contemplated by this Agreement. Buyers have incurred no obligations or liability
      for brokerage or finders’ fees or agents’ commissions or other similar payment
      in connection with the transactions contemplated by this Agreement.

     

    (k) Short
      Sales.
      From
      and after obtaining the knowledge of the transactions contemplated hereby,
      Buyer
      has not taken, and prior to the public announcement of the transaction Buyer
      shall not take, any action that has caused or will cause Buyer to have, directly
      or indirectly, sold or agreed to sell any shares of Common Stock, effected
      any
      short sale, whether or not against the box, established any “put equivalent
      position” (as defined in Rule 16a-1(h) under the Exchange Act) with respect to
      the Common Stock, granted any other right (including, without limitation, any
      put or call option) with respect to the Common Stock or with respect to any
      security that includes, related to or derives any significant part of its value
      from the Common Stock, whether or not, direct or indirectly, in order to hedge
      its positions in the Common Stock.

     

    3. REPRESENTATIONS
      AND WARRANTIES OF THE COMPANY.

     

    The
      Company represents and warrants to each of the Buyers that:

     

    (a) Organization
      and Qualification.
      The
      Company is duly incorporated or otherwise organized, validly existing and in
      good standing under the laws of the jurisdiction of its incorporation or
      organization, with the requisite power and authority to own and use its
      properties and assets and to carry on its business as currently conducted.
      The
      Company is not in violation of any of the provisions of its certificate or
      articles of incorporation, bylaws or other organizational or charter documents.
      The Company is duly qualified to conduct its business and is in good standing
      as
      a foreign corporation or other entity in each jurisdiction in which the nature
      of the business conducted or property owned by it makes such qualification
      necessary.

     

    (b) Authorization;
      Enforcement; Validity.
      The
      Company has the requisite corporate power and authority to enter into and
      perform its obligations under this Agreement, the Notes, the Registration Rights
      Agreement, the Irrevocable Transfer Agent Instructions, the Warrants and each
      of
      the other agreements entered into by the parties hereto in connection with
      the
      transactions contemplated by this Agreement (collectively, the “Transaction
      Documents”)
      and
      otherwise to carry out its obligations hereunder and thereunder (including
      to
      issue the Securities in accordance with the terms hereof and thereof). The
      execution and delivery of each of the Transaction Documents by the Company
      and
      the consummation by it of the transactions contemplated hereby and thereby,
      including without limitation the issuance of the Notes and the Warrants, the
      reservation for issuance and the issuance of the Conversion Shares issuable
      upon
      conversion of the Notes, the reservation for issuance and issuance of Warrant
      Shares issuable upon exercise of the Warrants, have been duly authorized by
      all
      necessary action on the part of the Company and no further action is required
      by
      the Company, its Board of Directors or its stockholders in connection therewith.
      Each Transaction Document has been (or upon delivery will have been) duly
      executed by the Company and, when delivered in accordance with the terms hereof,
      will constitute the valid and binding obligation of the Company enforceable
      against the Company in accordance with their respective terms, except as such
      enforceability may be limited by applicable bankruptcy, insolvency,
      reorganization, moratorium, liquidation or similar laws relating to, or
      affecting generally the enforcement of, creditors’ rights and remedies or by
      other equitable principles of general application.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (c) Issuance
      of Securities.
      The
      issuance of the Notes and Warrants have been duly authorized and, when issued
      and paid for in accordance with the Transaction Documents, will be duly and
      validly issued, fully paid and nonassessable, free and clear of all liens and
      encumbrances. The Company has reserved from its duly authorized capital stock
      the shares of Common Stock issuable pursuant to this Agreement and the Warrants
      in order to issue the Conversion Shares and the Warrant Shares.

     

    (d) No
      Conflicts.
      The
      execution, delivery and performance of the Transaction Documents by the Company
      and the consummation by the Company of the transactions contemplated hereby
      and
      thereby, including without limitation the issuance of the Notes and the
      Warrants, the reservation for issuance and the issuance of the Conversion Shares
      issuable upon conversion of the Notes, the reservation for issuance and issuance
      of Warrant Shares issuable upon exercise of the Warrants, do not and will not
      (i) conflict with or violate any provision of the certificate or articles of
      incorporation, bylaws or other organizational or charter documents of the
      Company or any Subsidiary, or (ii) conflict with, or constitute a default (or
      an
      event that with notice or lapse of time or both would become a default) under,
      or give to others any rights of termination, amendment, acceleration or
      cancellation (with or without notice, lapse of time or both) of, any agreement,
      credit facility, debt or other instrument (evidencing a Company debt or
      otherwise) or other understanding to which the Company or any Subsidiary is
      a
      party or by which any property or asset of the Company or any Subsidiary is
      bound or affected, or (iii) result in a violation of any law, rule, regulation,
      order, judgment, injunction, decree or other restriction of any court or
      governmental authority to which the Company or any Subsidiary is subject
      (including federal and state securities laws and regulations and the rules
      and
      regulations of the Nasdaq Stock Market (the “Principal
      Market”)),
      or
      by which any property or asset of the Company or any Subsidiary is bound or
      affected. 

     

    For
      purposes of this Agreement, “Subsidiary”
shall
      mean any corporation, partnership, joint venture, association or other business
      enterprise in which the Company owns, directly or indirectly, at least fifty
      percent (50%) of the outstanding securities or other interests, the holders
      of
      which are generally entitled to vote for the election of the board of directors
      or other governing body or otherwise exercise control of such
      entity.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    (e) Consents.
      The
      Company is not required to obtain any consent, waiver, authorization or order
      of, give any notice to, or make any filing or registration with, any court
      or
      other federal, state, local, foreign or other governmental authority or other
      Person in connection with the execution, delivery and performance by the Company
      of the Transaction Documents, other than (i) the filing with the United States
      Securities and Exchange Commission (the “Commission”) of
      one or
      more Registration Statements in accordance with the requirements of the
      Registration Rights Agreement, (ii) filings required by state securities laws,
      (iii) the filing of a Notice of Sale of Securities on Form D with the Commission
      under Regulation D of the 1933 Act, or (iv) registration with, any court,
      governmental agency or any regulatory or self-regulatory agency or any other
      Person in order for it to execute, deliver or perform any of its obligations
      under or contemplated by the Transaction Documents, in each case in accordance
      with the terms hereof or thereof. 

     

    (f) No
      General Solicitation; Placement Agent’s Fees.
      Neither
      the Company, nor any of its affiliates, nor any Person acting on its or their
      behalf, has engaged in any form of general solicitation or general advertising
      (within the meaning of Regulation D) in connection with the offer or sale of
      the
      Securities. The Company shall be responsible for the payment of any placement
      agent’s fees, financial advisory fees, or brokers’ commissions (other than for
      persons engaged by the Buyer or its investment advisor) relating to or arising
      out of the transactions contemplated hereby. The Company shall pay, and hold
      the
      Buyer harmless against, any liability, loss or expense (including, without
      limitation, attorney’s fees and out-of-pocket expenses) arising in connection
      with any such claim. 

     

    (g) No
      Integrated Offering.
      None of
      the Company, its Subsidiaries, any of their affiliates, and any Person acting
      on
      their behalf has, directly or indirectly, made any offers or sales of any
      security or solicited any offers to buy any security, under circumstances that
      would require registration of any of the Securities under the 1933 Act or cause
      this offering of the Securities to be integrated with prior offerings by the
      Company for purposes of the 1933 Act or any applicable stockholder approval
      provisions, including, without limitation, under the rules and regulations
      of
      any exchange or automated quotation system on which any of the securities of
      the
      Company are listed or designated.

     

    (h) Dilutive
      Effect.
      The
      Company understands and acknowledges that the number of Conversion Shares
      issuable upon conversion of the Notes and the Warrant Shares issuable upon
      exercise of the Warrants will increase in certain circumstances. The Company
      further acknowledges that its obligation to issue Conversion Shares upon
      conversion of the Notes in accordance with this Agreement and the Notes and
      its
      obligation to issue the Warrant Shares upon exercise of the Warrants in
      accordance with this Agreement and the Warrants is, in each case, absolute
      and
      unconditional regardless of the dilutive effect, which may be substantial,
      that
      such issuance may have on the ownership interests of other stockholders of
      the
      Company.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (i) SEC
      Documents; Financial Statements.
      The
      Company has filed all reports required to be filed by it under the 1933 Act
      and
      the Securities Exchange Act of 1934, as amended (the “1934 Act”),
      including pursuant to Section 13(a) or 15(d) thereof, during the two (2) years
      prior to the date hereof (the foregoing materials being collectively referred
      to
      herein as the“SEC
      Reports”)
      on a
      timely basis or has timely filed a valid extension of such time of filing and
      has filed any such SEC Reports prior to the expiration of any such extension.
      As
      of their respective dates, the SEC Reports complied in all material respects
      with the requirements of the 1933 Act and the 1934 Act and the rules and
      regulations of the Commission promulgated thereunder, and none of the SEC
      Reports, when filed, contained any untrue statement of a material fact or
      omitted to state a material fact required to be stated therein or necessary
      in
      order to make the statements therein, in light of the circumstances under which
      they were made, not misleading. The financial statements of the Company included
      in the SEC Reports comply in all material respects with applicable accounting
      requirements and the rules and regulations of the Commission with respect
      thereto as in effect at the time of filing. Such financial statements have
      been
      prepared in accordance with United States generally accepted accounting
      principles (“GAAP”)
      applied on a consistent basis during the periods involved, except as may be
      otherwise specified in such financial statements or the notes thereto, and
      fairly present in all material respects the financial position of the Company
      as
      of and for the dates thereof and the results of operations and cash flows for
      the periods then ended, subject, in the case of unaudited statements, to normal,
      immaterial, year-end audit adjustments. 

     

    (j) Sarbanes-Oxley
      Act.
      Except
      as set forth in Section 3(l) hereof, the Company is in compliance with any
      and
      all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective
      as of the date hereof, and any and all applicable rules and regulations
      promulgated by the SEC thereunder that are effective as of the date hereof,
      except where such noncompliance would not have, individually or in the
      aggregate, a Material Adverse Effect.

     

    For
      purposes of this Agreement, “Material
      Adverse Effect”
shall
      mean any circumstance, condition, change in or effect on the Company or its
      Subsidiaries that, individually or in the aggregate, is, or would reasonably
      be
      expected to be, materially adverse to the business, capitalization, assets,
      liabilities (contingent or otherwise), properties, results of operations, or
      condition, financial or otherwise, of the Company and its Subsidiaries, taken
      as
      a whole.

    

    (k) Absence
      of Certain Changes.
      Since
      the date of the latest audited financial statements included within the SEC
      Reports, except as specifically disclosed in the SEC Reports, (i) there has
      been
      no event, occurrence or development that has had or that could reasonably be
      expected to result in a Material Adverse Effect on the Company, (ii) the Company
      has not incurred any liabilities (contingent or otherwise) other than (A) trade
      payables, accrued expenses and other liabilities incurred in the ordinary course
      of business consistent with past practice and (B) liabilities not required
      to be
      reflected in the Company's financial statements pursuant to GAAP or required
      to
      be disclosed in filings made with the Commission, (iii) the Company has not
      altered its method of accounting or the identity of its auditors, (iv) the
      Company has not declared or made any dividend or distribution of cash or other
      property to its stockholders or purchased, redeemed or made any agreements
      to
      purchase or redeem any shares of its capital stock, and (v) the Company has
      not
      issued any equity securities to any officer, director or affiliate, except
      pursuant to existing Company stock option or restricted stock plans or otherwise
      in the ordinary course of business. The Company does not have pending before
      the
      Commission any request for confidential treatment of information. 

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (l) Disclosure
      Controls and Procedures.
      Except
      as set forth on Schedule 3(l), the Company is in the process of establishing
      (i)
      disclosure controls and procedures (as such term is defined in Rule 13a-15(e)
      under the 1934 Act), which are (a) designed to ensure that information required
      to be disclosed by the Company in the reports that it files or submits under
      the
      1934 Act is recorded, processed, summarized and reported, within the time
      periods specified in the Commission's rules and forms, and is accumulated and
      communicated to the Company's management, including its principal executive
      officer or officers and principal financial officer or officers, as appropriate,
      to allow timely decisions regarding disclosure and (b) effective in all material
      respects to perform the functions for which they were established and (ii)
      a
      system of internal controls that complies with the requirements of the 1934
      Act
      and has been designed by the Company's principal executive officer and principal
      financial officer, or under their supervision, sufficient to provide reasonable
      assurances that: (A) transactions are executed in accordance with management’s
      general or specific authorization; (B) transactions are recorded as necessary
      to
      permit preparation of financial statements in conformity with GAAP, the 1933
      Act
      and the 1934 Act and the rules and regulations of the Commission thereunder,
      and
      to maintain accountability for assets; (C) access to assets is permitted only
      in
      accordance with management’s general or specific authorization; and (D) recorded
      assets are compared with existing assets at reasonable intervals and appropriate
      action is taken with respect to any differences. 

     

    (m) Equity
      Capitalization.
      Except
      as set forth on Schedule
      3(m)
      hereof,
      the number of shares and type of all authorized, issued and outstanding capital
      stock of the Company, and all shares of Common Stock reserved for issuance
      under
      the Company’s various option and incentive plans, is specified in the SEC
      Reports. Except as specified in the SEC Reports, no securities of the Company
      are entitled to preemptive or similar rights, and no Person has any right of
      first refusal, preemptive right, right of participation, or any similar right
      to
      participate in the transactions contemplated by the Transaction Documents.
      Except as specified in the SEC Reports, there are no outstanding options,
      warrants, scrip rights to subscribe to, calls or commitments of any character
      whatsoever relating to, or securities, rights or obligations convertible into
      or
      exchangeable for, or giving any Person any right to subscribe for or acquire,
      any shares of Common Stock, or contracts, commitments, understandings or
      arrangements by which the Company is or may become bound to issue additional
      shares of Common Stock, or securities or rights convertible or exchangeable
      into
      shares of Common Stock. The issue and sale of the Securities will not,
      immediately or with the passage of time, obligate the Company to issue shares
      of
      Common Stock or other securities to any Person (other than the undersigned)
      and
      will not result in a right of any holder of Company securities to adjust the
      exercise, conversion, exchange or reset price.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (n) Indebtedness
      and Other Contracts.
      Except
      as
      disclosed in Schedule
      3(n),
      neither
      the Company nor any of its Subsidiaries (i) has any outstanding Indebtedness
      (as
      defined below), (ii) is a party to any contract, agreement or instrument, the
      violation of which, or default under which, by the other party(ies) to such
      contract, agreement or instrument would result in a Material Adverse Effect,
      (iii) is in violation of any term of or in default under any contract, agreement
      or instrument relating to any Indebtedness, except where such violations and
      defaults would not result, individually or in the aggregate, in a Material
      Adverse Effect, or (iv) is a party to any contract, agreement or instrument
      relating to any Indebtedness, the performance of which, in the judgment of
      the
      Company’s officers, has or is expected to have a Material Adverse Effect.
Schedule
      3(n)
      provides
      a detailed description of the material terms of any such outstanding
      Indebtedness. For purposes of this Agreement: (x) “Indebtedness”
of
      any
      Person means, without duplication (A) all indebtedness for borrowed money,
      (B)
      all reimbursement or payment obligations with respect to letters of credit,
      surety bonds and other similar instruments, (C) all obligations evidenced by
      notes, bonds, debentures or similar instruments, including obligations so
      evidenced incurred in connection with the acquisition of property, assets or
      businesses, (D) all indebtedness created or arising under any conditional sale
      or other title retention agreement, or incurred as financing, in either case
      with respect to any property or assets acquired with the proceeds of such
      indebtedness (even though the rights and remedies of the seller or bank under
      such agreement in the event of default are limited to repossession or sale
      of
      such property), (E) all indebtedness referred to in clauses (A) through (D)
      above secured by (or for which the holder of such Indebtedness has an existing
      right, contingent or otherwise, to be secured by) any mortgage, lien, pledge,
      charge, security interest or other encumbrance upon or in any property or assets
      (including accounts and contract rights) owned by any Person, even though the
      Person which owns such assets or property has not assumed or become liable
      for
      the payment of such indebtedness, and (F) all Contingent Obligations in respect
      of indebtedness or obligations of others of the kinds referred to in clauses
      (A)
      through (E) above; (y) “Contingent
      Obligation”
means,
      as to any Person, any direct or indirect liability, contingent or otherwise,
      of
      that Person with respect to any indebtedness, lease, dividend or other
      obligation of another Person if the primary purpose or intent of the Person
      incurring such liability, or the primary effect thereof, is to provide assurance
      to the obligee of such liability that such liability will be paid or discharged,
      or that any agreements relating thereto will be complied with, or that the
      holders of such liability will be protected (in whole or in part) against loss
      with respect thereto; and (z) “Person”
means
      an individual, a limited liability company, a partnership, a joint venture,
      a
      corporation, a trust, an unincorporated organization and a government or any
      department or agency thereof. 

     

    (o) Ranking
      of Notes.
      Except
      as set forth on Schedule
      3(o),
      no
      Indebtedness of the Company is senior to or ranks pari
      passu
      with the
      Notes in right of payment, whether with respect of payment of redemptions,
      interest, damages or upon liquidation or dissolution or otherwise.

     

    (p) Form
      S-3 Eligibility.
      The
      Company is eligible to register the Conversion Shares and the Warrant Shares
      for
      resale by the Buyers using Form S-3 promulgated under the 1933 Act.

     

    (q) Manipulation
      of Price.
      The
      Company has not, and to its knowledge no one acting on its behalf has, (i)
      taken, directly or indirectly, any action designed to cause or to result in
      the
      stabilization or manipulation of the price of any security of the Company to
      facilitate the sale or resale of any of the Securities, or (ii) sold, bid for,
      purchased, or paid any compensation for soliciting purchases of, any of the
      Securities.

     

    (r) Disclosure.
      The
      Company confirms that neither it nor any other Person acting on its behalf
      has
      provided the Buyer or its agents or counsel with any information that
      constitutes or could reasonably be expected to constitute material, nonpublic
      information. The Company understands and confirms that the Buyer will rely
      on
      the foregoing representations in effecting transactions in securities of the
      Company. No event or circumstance has occurred or information exists with
      respect to the Company or any of its Subsidiaries or its or their business,
      properties, prospects, operations or financial conditions, which, under
      applicable U.S. law, rule or regulation, requires public disclosure or
      announcement by the Company but which has not been so publicly announced or
      disclosed.

     

    (s) Foreign
      Corrupt Practices Act.
      The
      Company has not made, offered or agreed to offer anything of value to any
      government official, political party or candidate for political office (or
      any
      Person that the Company knows or has reason to know will offer anything of
      value
      to any such Person) in violation of the Foreign Corrupt Practices Act of 1977,
      as amended.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (t) Compliance
      with Money Laundering Rules.
      The
      business and operations of the Company are being conducted in compliance in
      all
      material respects with, and are not in default in any material respect under
      any
      applicable statutes, laws, rules, regulations, judgments, orders or decrees
      of
      and commitments to any United States governmental authority relating to money
      laundering, bank secrecy, anti-bribery and other corrupt practices. There is
      no
      pending or threatened charge by any United States governmental authority that
      the Company has materially violated any such law, rule, regulation, judgment,
      order, decree or commitment, nor is there any pending or threatened
      investigation by any United States governmental authority with respect to
      possible material violations of any such law, rule, regulation, judgment, order,
      decree or commitment, except for such violations which would not, individually
      or in the aggregate, result in a Material Adverse Effect.

     

    4. COVENANTS.

     

    (a) Efforts
      to Satisfy Conditions.
      Each
      party shall use its commercially reasonable efforts to satisfy each of the
      conditions to be satisfied by it as provided in Sections 6 and 7 of this
      Agreement.

     

    (b) Form
      D
      and Blue Sky.
      The
      Company agrees to file a Form D with respect to the Securities as required
      under
      Regulation D and to provide a copy thereof to the Buyer promptly after such
      filing. The Company shall, on or before the Closing Date, take such action
      as
      the Company shall reasonably determine is necessary in order to obtain an
      exemption for or to qualify the Securities for sale to the Buyer at the Closing
      pursuant to this Agreement under applicable securities or “Blue Sky” laws of the
      states of the United States (or to obtain an exemption from such qualification),
      and shall provide evidence of any such action so taken to the Buyer on or prior
      to the Closing Date. The Company shall make all filings and reports relating
      to
      the offer and sale of the Securities required under applicable securities or
      “Blue Sky” laws of the states of the United States following the Closing
      Date.

     

    (c) Reporting
      Status.
      Until
      the date on which the Investors (as defined in the Registration Rights
      Agreement) shall have sold all the Conversion Shares and Warrant
      Shares and
      none
      of the Notes or Warrants
      is outstanding (the “Reporting
      Period”),
      the
      Company shall timely file all reports required to be filed with the SEC pursuant
      to the 1934 Act, and the Company shall not terminate its status as an issuer
      required to file reports under the 1934 Act even if the 1934 Act or the rules
      and regulations thereunder would otherwise permit such termination.

     

    (d) Financial
      Information.
      Unless
      the following are filed with the SEC through EDGAR and are available to the
      public through the EDGAR system, the Company agrees to send the following to
      each Investor during the Reporting Period (i) within one (1) Business Day after
      the filing thereof with the SEC, a copy of its Annual Reports on Form 10-K
      or
      10-KSB, any interim reports or any consolidated balance sheets, income
      statements, stockholders’ equity statements and/or cash flow statements for any
      period other than annual, any Current Reports on Form 8-K and any registration
      statements (other than on Form S-8) or amendments filed pursuant to the 1933
      Act, (ii) within one (1) Business Day after the release thereof, facsimile
      copies of all material press releases issued by the Company or any of its
      Subsidiaries, (iii) within two (2) Business Days after the release thereof,
      facsimile copies of all other press releases issued by the Company or any of
      its
      Subsidiaries and (iv) copies of any notices and other information made available
      or given to the stockholders of the Company generally, contemporaneously with
      the making available or giving thereof to the stockholders.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (e) Listing.
      The
      Company shall use its commercially reasonable efforts to promptly secure the
      listing of all of the Registrable Securities (as defined in the Registration
      Rights Agreement) upon each national securities exchange and automated quotation
      system, if any, upon which the Common Stock is then listed (subject to official
      notice of issuance) and shall use its commercially reasonable efforts to
      maintain such listing of all Registrable Securities from time to time issuable
      under the terms of the Transaction Documents. The Company shall use its
      commercially reasonable efforts to maintain the Common Stock’s authorization for
      quotation on the Principal Market. The Company shall not, nor shall it cause
      or
      permit any of its Subsidiaries to, take any action that would be reasonably
      expected to result in the delisting or suspension of the Common Stock on the
      Principal Market. The Company shall pay all fees and expenses in connection
      with
      satisfying its obligations under this Section 4(e).

     

    (f) Fees.
      Upon
      the Closing, the Company shall reimburse the Buyer or its designee(s) for all
      reasonable costs and expenses incurred in connection with the transactions
      contemplated by the Transaction Documents (including all reasonable legal fees
      and disbursements in connection therewith, documentation and implementation
      of
      the transactions contemplated by the Transaction Documents and due diligence
      in
      connection therewith), which amount shall be withheld by the Buyer from its
      Purchase Price at the Closing. The Company shall be responsible for the payment
      of any placement agent’s fees, financial advisory fees, or broker’s commissions
      (other than for Persons engaged by the Buyer) relating to or arising out of
      the
      transactions contemplated hereby, including, without limitation, any fees or
      commissions payable to the Agent. The Company shall pay, and hold the Buyer
      harmless against, any liability, loss or expense (including, without limitation,
      reasonable attorney’s fees and out-of-pocket expenses) arising in connection
      with any claim relating to any such payment. Except as otherwise set forth
      in
      the Transaction Documents, each party to this Agreement shall bear its own
      expenses in connection with the sale of the Securities to the
      Buyer.

     

    (g) Pledge
      of Securities.
      The
      Company acknowledges and agrees that the Securities may be pledged by the Buyer
      in connection with a bona fide margin agreement or other loan or financing
      arrangement that is secured by the Securities. The pledge of Securities shall
      not be deemed to be a transfer, sale or assignment of the Securities hereunder,
      and the Buyer shall not be required to provide the Company with any notice
      thereof or otherwise make any delivery to the Company pursuant to this Agreement
      or any other Transaction Document, including, without limitation, Section 2(f)
      hereof; provided that the Buyer and its pledgee shall be required to comply
      with
      the provisions of Section 2(f) hereof in order to effect a sale, transfer or
      assignment of Securities to such pledgee. The Company hereby agrees to execute
      and deliver such documentation as a pledgee of the Securities may reasonably
      request in connection with a pledge of the Securities to such pledgee by the
      Buyer.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (h) Disclosure
      of Transactions and Other Material Information.
      On or
      before 8:30 a.m., New York Time, on the
      first
      Trading Day following the date hereof, the Company shall issue a press release
      describing the terms of the transactions contemplated by the Transaction
      Documents. On or before 8:30 a.m., New York Time, on the
      fourth Trading Day following the date hereof, the Company shall file a Current
      Report on Form 8-K describing the terms of the transactions contemplated by
      the
      Transaction Documents in the form required by the 1934 Act and the substance
      of
      the disclosure set forth in Section 3(l) hereof, and attaching the material
      Transaction Documents (including, without limitation, this Agreement (and all
      schedules to this Agreement), the form of each of the Notes, the form of
      Warrant, and the Registration Rights Agreement as exhibits to such filing
      (including all attachments, the “8-K
      Filing”).
      From
      and after the Closing, the Buyer shall not be in possession of any material,
      nonpublic information received from the Company, any of its Subsidiaries or
      any
      of its respective officers, directors, employees or agents, that is not
      disclosed in this Agreement or the 8-K Filing. The Company shall not, and shall
      cause each of its Subsidiaries and its and each of their respective officers,
      directors, employees and agents, not to, provide the Buyer with, and the Buyer
      shall not request, any material, nonpublic information regarding the Company
      or
      any of its Subsidiaries from and after the Closing without the express written
      consent of the Buyer. In the event of a breach of the foregoing covenant by
      the
      Company, any of its Subsidiaries, or any of its or their respective officers,
      directors, employees and agents, in addition to any other remedy provided herein
      or in the Transaction Documents, the Buyer shall have the right to request
      the
      Company to make a public disclosure, in the form of a press release, public
      advertisement or otherwise, of such material, nonpublic information without
      the
      prior approval by the Company, its Subsidiaries, or any of its or their
      respective officers, directors, employees or agents. The Buyer shall not have
      any liability to the Company, its Subsidiaries, or any of its or their
      respective officers, directors, employees, stockholders or agents for any such
      disclosure. Subject to the foregoing, neither the Company nor the Buyer shall
      issue any press releases or any other public statements with respect to the
      transactions contemplated hereby; provided,
      however,
      that
      the Company shall be entitled, without the prior approval of the Buyer, to
      make
      any press release or other public disclosure with respect to such transactions
      (i) in substantial conformity with the 8-K Filing and contemporaneously
      therewith and (ii) as is required by applicable law and regulations (provided
      that in the case of clause (i) the Buyer shall be consulted by the Company
      in
      connection with and given an opportunity to review and comment on any such
      press
      release or other public disclosure prior to its release). Notwithstanding the
      foregoing, the Company shall not publicly disclose the name of the Buyer, or
      include the name of the Buyer in any filing with the SEC or any regulatory
      agency or the Principal Market, without the prior written consent of such Buyer,
      except (i) for disclosure thereof in the 8-K Filing or Registration Statement
      or
      (ii) as required by law or Principal Market regulations or any order of any
      court or other governmental agency, in which case the Company shall provide
      such
      Buyer with prior notice of such disclosure.

     

    (i) Integration.
      None of
      the Company, its Subsidiaries, their affiliates and any Person acting on their
      behalf will take any action or steps referred to in Section 3(g) that would
      require registration of any of the Securities under the 1933 Act or cause the
      offering of the Securities to be integrated with other offerings.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (j) Form
      S-3 Eligibility.
      The
      Company shall use its commercially reasonable efforts to maintain the
      eligibility of its registration statement on Form S-3 so that it is available
      for the registration of the resale of Registrable Securities.

     

    (k) Holding
      Period.
      For the
      purposes of Rule 144, the Company acknowledges that the holding period of the
      Conversion Shares may be tacked onto the holding period of the Notes and the
      holding period of the Warrant Shares may be tacked onto the holding period
      of
      the Warrants (in the case of Cashless Exercise (as defined in the Warrants))
      and
      the Company agrees not to take a position contrary to this Section
      4(k).

     

    (l) Restrictions
      on Future Indebtedness.
      For so
      long as the Notes remain outstanding, the Company shall not, without the prior
      written consent of the holders of at least a majority of the aggregate number
      of
      Registrable Securities issued and issuable hereunder, assume or incur (by
      guaranty or otherwise) Indebtedness, other than purchase
      money mortgages and installment purchases on hog farm acquisitions,
      that (i)
      ranks senior or pari
      passu
      with the
      Notes, or (ii) individually or in the aggregate, exceeds $250,000.

     

    5. REGISTER;
      TRANSFER AGENT INSTRUCTIONS.

     

    (a) Register.
      The
      Company shall maintain at its principal executive offices (or such other office
      or agency of the Company as it may designate by notice to each holder of
      Securities), a register for the Notes and the Warrants, in which the Company
      shall record the name and address of the Person in whose name the Notes
      and the
      Warrants have been issued (including the name and address of each transferee),
      the principal amount of Notes held by such Person, the number of Conversion
      Shares issuable upon conversion of the Notes and Warrant Shares issuable upon
      exercise of the Warrants held by such Person. The Company shall keep the
      register open and available at all times during business hours for inspection
      of
      any Buyer or its legal representatives.

     

    (b) Transfer
      Agent Instructions.
      The
      Company shall issue irrevocable instructions to its transfer agent, and any
      subsequent transfer agent, to issue certificates or credit shares to the
      applicable balance accounts at The Depository Trust Company (“DTC”),
      registered in the name of each Buyer or its respective nominee(s), for the
      Conversion Shares and the Warrant Shares issued at the Closing or upon
      conversion of the Notes or exercise of the Warrants in such amounts as specified
      from time to time by each Buyer to the Company upon conversion of the Notes
      or
      exercise of the Warrants in the form of Exhibit D attached hereto (the
“Irrevocable
      Transfer Agent Instructions”).
      The
      Company warrants that no instruction other than the Irrevocable Transfer Agent
      Instructions referred to in this Section 5(b), and stop transfer instructions
      to
      give effect to Section 2(g) hereof, will be given by the Company to its transfer
      agent, and that the Securities shall otherwise be freely transferable on the
      books and records of the Company as and to the extent provided in this Agreement
      and the other Transaction Documents. If a Buyer effects a sale, assignment
      or
      transfer of the Securities in accordance with Section 2(f), the Company shall
      permit the transfer and shall promptly instruct its transfer agent to issue
      one
      or more certificates or credit shares to the applicable balance accounts at
      DTC
      in such name and in such denominations as specified by such Buyer to effect
      such
      sale, transfer or assignment. In the event that such sale, assignment or
      transfer involves Conversion Shares or Warrant Shares sold, assigned or
      transferred pursuant to an effective registration statement or pursuant to
      Rule
      144, the transfer agent shall issue such Securities to the Buyer, assignee
      or
      transferee, as the case may be, without any restrictive legend. The Company
      acknowledges that a breach by it of its obligations hereunder will cause
      irreparable harm to a Buyer. Accordingly, the Company acknowledges that the
      remedy at law for a breach of its obligations under this Section 5(b) will
      be
      inadequate and agrees, in the event of a breach or threatened breach by the
      Company of the provisions of this Section 5(b), that a Buyer shall be entitled,
      in addition to all other available remedies, to an order and/or injunction
      restraining any breach and requiring immediate issuance and transfer, without
      the necessity of showing economic loss and without any bond or other security
      being required.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    6. CONDITIONS
      TO THE COMPANY’S OBLIGATION TO SELL. The obligation of the Company hereunder
      to issue and sell the Notes and the related Warrants to each Buyer at the
      Closing is subject to the satisfaction, at or before the Closing Date, of each
      of the following conditions, provided that these conditions are for the
      Company’s sole benefit and may be waived by the Company at any time in its sole
      discretion by providing each Buyer with prior written notice
      thereof:

     

    (a) Such
      Buyer shall have executed each of the Transaction Documents to which it is
      a
      party and delivered the same to the Company.

     

    (b) Such
      Buyer and each other Buyer shall have delivered to the Company the Purchase
      Price (less any amounts withheld pursuant to Section 4(f)) for the Notes and
      the
      related Warrants and being purchased by such Buyer at the Closing by wire
      transfer of immediately available funds pursuant to the wire instructions
      provided by the Company.

     

    (c) The
      representations and warranties of such Buyer shall be true and correct in all
      material respects (except for those representations and warranties that are
      qualified by materiality or Material Adverse Effect, which shall be true and
      correct in all respects) as of the date of this Agreement and (except to the
      extent such representations and warranties speak as of an earlier date) as
      of
      the Closing Date as though made on and as of the Closing Date, and such Buyer
      shall have performed, satisfied and complied in all material respects with
      the
      covenants, agreements and conditions required by this Agreement to be performed,
      satisfied or complied with by such Buyer at or prior to the Closing
      Date.

     

    7. CONDITIONS
      TO EACH BUYER’S OBLIGATION TO PURCHASE. The obligation of each Buyer
      hereunder to purchase the Notes and
      the
      related Warrants at the Closing is subject to the satisfaction, at or before
      the
      Closing Date, of each of the following conditions, provided that these
      conditions are for each Buyer’s sole benefit and may be waived by such Buyer at
      any time in its sole discretion by providing the Company with prior written
      notice thereof:

     

    (a) The
      Company shall have executed and delivered to such Buyer (i) each of the
      Transaction Documents, (ii) the Notes (in such principal amounts as such Buyer
      shall request) being purchased by such Buyer at the Closing pursuant to this
      Agreement and (iii) the Warrants (in such amounts as such Buyer shall request)
      being purchased by such Buyer at the Closing pursuant to this
      Agreement.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (b) Such
      Buyer shall have received the opinions of (i) Pryor Cashman, LLP, the Company’s
      outside counsel and (ii) Hale Lane Peek Dennison and Howard, the Company’s
      Nevada counsel, each dated as of the Closing Date, which, when taken together,
      shall be in substantially the form of Exhibit E
      attached
      hereto.

     

    (c) The
      Company shall have delivered to such Buyer a copy of the Irrevocable Transfer
      Agent Instructions, in the form of Exhibit D
      attached
      hereto, which instructions shall have been delivered to and acknowledged in
      writing by the Company’s transfer agent.

     

    (d) The
      Company shall have delivered to such Buyer (x) a certificate evidencing the
      formation and good standing of the Company in such entity’s jurisdiction of
      formation issued by the Secretary of State (or comparable office) of such
      jurisdiction, as of a date within ten (10) days of the Closing Date and (y)
      a
      facsimile or other acceptable method of confirmation from such Secretary of
      State (or comparable office) as of the Closing Date as to the continued good
      standing of such entity.

     

    (e) The
      representations and warranties of the Company shall be true and correct in
      all
      material respects (except for those representations and warranties that are
      qualified by materiality or Material Adverse Effect, which shall be true and
      correct in all respects) as of the date of this Agreement and (except to the
      extent such representations and warranties speak as of an earlier date) as
      of
      the Closing Date as though made on and as of the Closing Date, and the Company
      shall have performed, satisfied and complied in all material respects with
      the
      covenants, agreements and conditions required by this Agreement to be performed,
      satisfied or complied with by the Company at or prior to the Closing Date and
      such Buyer shall have received a certificate dated as of the Closing Date
      executed by an authorized officer of the Company to such effect.

     

    (f) The
      Company shall have delivered to such Buyer a certified copy of the Articles
      of
      Incorporation as certified by the Secretary of State of the State of Nevada
      within five (5) days of the Closing Date.

     

    (g) The
      Common Stock (I) shall be designated for quotation or listed on the Principal
      Market and (II) shall not have been suspended, as of the Closing Date, by the
      Commission or the Principal Market from trading on the Principal Market nor
      shall suspension by the Commission or the Principal Market have been threatened,
      as of the Closing Date, either (A) in writing by the Commission or the Principal
      Market or (B) by falling below the minimum listing maintenance requirements
      of
      the Principal Market.

     

    (h) The
      Company shall have obtained all governmental, regulatory or third party consents
      and approvals, if any, necessary for the sale of the Securities.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (i) The
      Company shall have delivered to such Buyer a notice stating that (a) the Company
      has received an aggregate of $22 million from the issuance of its common stock
      under its shelf registration statement on Form S-3 (Registration Number
333-148386)
      (the “Registration Funds”) and (b) that the Registration Funds (except
      approximately US$3,000,000, which shall be funded in RMB) are being held in
      a
      limited access account (to which the Company has no access) until such funds
      are
      released to the Company simultaneously upon the closing of the transactions
      contemplated hereby.

     

    8. TERMINATION.
      In the event that the Closing shall not have occurred with respect to a buyer
      on
      or before Monday, March 3, 2008 due to the Company’s or such Buyer’s failure to
      satisfy the conditions set forth in Sections 6 and 7 above (and the nonbreaching
      party’s failure to waive such unsatisfied condition(s)), the nonbreaching party
      shall have the option to terminate this Agreement with respect to such breaching
      party at the close of business on such date without liability of any party
      to
      any other party.

     

    9. MISCELLANEOUS.

     

    (a) Governing
      Law; Jurisdiction; Jury Trial.
      All
      questions concerning the construction, validity, enforcement and interpretation
      of this Agreement shall be governed by the internal laws of the State of New
      York, without giving effect to any choice of law or conflict of law provision
      or
      rule (whether of the State of New York or any other jurisdictions) that would
      cause the application of the laws of any jurisdictions other than the State
      of
      New York. Each party hereby irrevocably submits to the exclusive jurisdiction
      of
      the state and federal courts sitting in The City of New York, Borough of
      Manhattan, for the adjudication of any dispute hereunder or in connection
      herewith or with any transaction contemplated hereby or discussed herein, and
      hereby irrevocably waives, and agrees not to assert in any suit, action or
      proceeding, any claim that it is not personally subject to the jurisdiction
      of
      any such court, that such suit, action or proceeding is brought in an
      inconvenient forum or that the venue of such suit, action or proceeding is
      improper. Each party hereby irrevocably waives personal service of process
      and
      consents to process being served in any such suit, action or proceeding by
      mailing a copy thereof to such party at the address for such notices to it
      under
      this Agreement and agrees that such service shall constitute good and sufficient
      service of process and notice thereof. Nothing contained herein shall be deemed
      to limit in any way any right to serve process in any manner permitted by law.
      EACH
      PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO
      REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN
      CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED
      HEREBY. 

     

    (b) Counterparts.
      This
      Agreement may be executed in two or more identical counterparts, all of which
      shall be considered one and the same agreement and shall become effective when
      counterparts have been signed by each party and delivered to the other party;
      provided that a facsimile signature shall be considered due execution and shall
      be binding upon the signatory thereto with the same force and effect as if
      the
      signature were an original, not a facsimile signature.

     

    (c) Headings.
      The
      headings of this Agreement are for convenience of reference and shall not form
      part of, or affect the interpretation of, this Agreement.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (d) Severability.
      If any
      provision of this Agreement shall be invalid or unenforceable in any
      jurisdiction, such invalidity or unenforceability shall not affect the validity
      or enforceability of the remainder of this Agreement in that jurisdiction or
      the
      validity or enforceability of any provision of this Agreement in any other
      jurisdiction.

     

    (e) Entire
      Agreement; Amendments.
      This
      Agreement supersedes all other prior oral or written agreements between the
      Buyer, the Company, their affiliates and Persons acting on their behalf with
      respect to the matters discussed herein, and this Agreement and the instruments
      referenced herein contain the entire understanding of the parties with respect
      to the matters covered herein and therein and, except as specifically set forth
      herein or therein, neither the Company nor the Buyer makes any representation,
      warranty, covenant or undertaking with respect to such matters. No provision
      of
      this Agreement may be amended other than by an instrument in writing signed
      by
      the Company and
      the
      holders of at least a majority of the aggregate number of Registrable Securities
      issued and issuable hereunder,
      and any
      amendment to this Agreement made in conformity with the provisions of this
      Section 9(e) shall be binding on the Buyer and holders of Securities, as
      applicable. No provision hereof may be waived other than by an instrument in
      writing signed by the party against whom enforcement is sought. No such
      amendment shall be effective to the extent that it applies to less than all
      of
      the holders of the applicable Securities then outstanding. No consideration
      shall be offered or paid to any Person to amend or consent to a waiver or
      modification of any provision of any of the Transaction Documents unless the
      same consideration also is offered to all of the parties to the Transaction
      Documents, holders of Notes, or holders of the Warrants, as the case may be.
      The
      Company has not, directly or indirectly, made any agreements with the Buyer
      relating to the terms or conditions of the transactions contemplated by the
      Transaction Documents except as set forth in the Transaction
      Documents.

     

    (f) Notices.
      Any
      notices, consents, waivers or other communications required or permitted to
      be
      given under the terms of this Agreement must be in writing and will be deemed
      to
      have been delivered: (i) upon receipt, when delivered personally; (ii) upon
      receipt, when sent by facsimile (provided confirmation of transmission is
      mechanically or electronically generated and kept on file by the sending party);
      or (iii) one Business Day after deposit with an overnight courier service,
      in
      each case properly addressed to the party to receive the same. The addresses
      and
      facsimile numbers for such communications shall be:

     

    If
      to the
      Company:

     

    Agfeed
      Industries, Inc.

    1095
      Qinglan Avenue

    Economic
      and Technology Development Zone

    Nanchang
      City

    Jiangxi
      Province

    
      	
            	Telephone:	
              86-791-2189636

            

    

    
      	
            	Facsimile:	
              86-791-2189636

            

    

    
      	
            	Attention:	
              Dr.
                Songyan Li

            

    

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    Copy
      to:

     

    Pryor
      Cashman, LLP

    410
      Park
      Avenue

    New
      York,
      NY 10022

    
      	
            	Telephone:	
              (212)
                326-0879

            

    

    
      	
            	Facsimile:	
              (212)798-6391
                

            

    

    
      	
            	Attention:	
              Selig
                D. Sacks, Esq.

            

    

    

    If
      to the
      Transfer Agent:

     

    Interwest
      Transfer Company, Inc.

    1981
      East
      Murray Holladay Road, Suite 100

    P.O.
      Box
      17136

    Salt
      Lake
      City, Ut 84117

    
      	
            	Telephone:	
              (801)272-9294

            

    

    
      	
            	Facsimile:	
              (801)277-3147

            

    

    
      	
            	Attention:	
              Melinda
                Orth

            

    

     

    If
      to a
      Buyer, to its address and facsimile number set forth on the Schedule of Buyers,
      with copies to such Buyer’s representatives as set forth on the Schedule of
      Buyers, or to such other address and/or facsimile number and/or to the attention
      of such other Person as the recipient party has specified by written notice
      given to each other party five (5) days prior to the effectiveness of such
      change. Written confirmation of receipt (A) given by the recipient of such
      notice, consent, waiver or other communication, (B) mechanically or
      electronically generated by the sender’s facsimile machine containing the time,
      date, recipient facsimile number and an image of the first page of such
      transmission or (C) provided by an overnight courier service shall be rebuttable
      evidence of personal service, receipt by facsimile or receipt from an overnight
      courier service in accordance with clause (i), (ii) or (iii) above,
      respectively; provided however that the foregoing clause (B) shall only be
      valid
      if such communication contained in the facsimile is delivered by an overnight
      courier service within 24 hours of the transmission of facsimile.

     

    (g) Successors
      and Assigns.
      This
      Agreement shall be binding upon and inure to the benefit of the parties and
      their respective successors and assigns, including any purchasers of the Notes
      or the Warrants. The Company shall not assign this Agreement or any rights
      or
      obligations hereunder without the prior written consent of the holders of at
      least a majority of the aggregate number of Registrable Securities issued and
      issuable hereunder, including by way of a Fundamental Transaction (unless the
      Company is in compliance with the applicable provisions governing Fundamental
      Transactions set forth in the Notes and the Warrants). A Buyer may assign some
      or all of its rights hereunder without the consent of the Company, in which
      event such assignee shall be deemed to be a Buyer hereunder with respect to
      such
      assigned rights.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (h) No
      Third Party Beneficiaries.
      This
      Agreement is intended for the benefit of the parties hereto and their respective
      permitted successors and assigns, and is not for the benefit of, nor may any
      provision hereof be enforced by, any other Person.

     

    (i) Survival.
      Unless
      this Agreement is terminated under Section 8, the representations and warranties
      of the Company and the Buyers contained in Sections 2 and 3 and the agreements
      and covenants set forth in Sections 4, 5 and 9 shall survive the Closing. Each
      Buyer shall be responsible only for its own representations, warranties,
      agreements and covenants hereunder.

     

    (j) Further
      Assurances.
      Each
      party shall do and perform, or cause to be done and performed, all such further
      acts and things, and shall execute and deliver all such other agreements,
      certificates, instruments and documents, as any other party may reasonably
      request to carry out the intent and accomplish the purposes of this Agreement
      and the consummation of the transactions contemplated hereby.

     

    (k) No
      Strict Construction.
      The
      language used in this Agreement will be deemed to be the language chosen by
      the
      parties to express their mutual intent, and no rules of strict construction
      will
      be applied against any party.

     

    (l) Independent
      Nature of Buyers’ Obligations and Rights.
      The
      obligations of each Buyer under any Transaction Document are several and not
      joint with the obligations of any other Buyer, and no Buyer shall be responsible
      in any way for the performance of the obligations of any other Buyer under
      any
      Transaction Document. Nothing contained herein or in any other Transaction
      Document, and no action taken by any Buyer pursuant hereto or thereto, shall
      be
      deemed to constitute the Buyers as a partnership, an association, a joint
      venture or any other kind of entity, or create a presumption that the Buyers
      are
      in any way acting in concert or as a group with respect to such obligations
      or
      the transactions contemplated by the Transaction Documents. Each Buyer confirms
      that it has independently participated in the negotiation of the transaction
      contemplated hereby with the advice of its own counsel and advisors. Each Buyer
      shall be entitled to independently protect and enforce its rights, including,
      without limitation, the rights arising out of this Agreement or out of any
      other
      Transaction Documents, and it shall not be necessary for any other Buyer to
      be
      joined as an additional party in any proceeding for such purpose.

     

    (m) Remedies.
      Each
      Buyer and each holder of the Securities shall have all rights and remedies
      set
      forth in the Transaction Documents and all rights and remedies which such
      holders have been granted at any time under any other agreement or contract
      and
      all of the rights which such holders have under any law. Any Person having
      any
      rights under any provision of this Agreement shall be entitled to enforce such
      rights specifically (without posting a bond or other security), to recover
      damages by reason of any breach of any provision of this Agreement and to
      exercise all other rights granted by law. Furthermore, the Company recognizes
      that in the event that it fails to perform, observe, or discharge any or all
      of
      its obligations under the Transaction Documents, any remedy at law may prove
      to
      be inadequate relief to such Buyer. The Company therefore agrees that each
      Buyer
      shall be entitled to seek temporary and permanent injunctive relief in any
      such
      case without the necessity of proving actual damages and without posting a
      bond
      or other security.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    [Signature
      Page Follows]

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    IN
      WITNESS WHEREOF,
      each
      Buyer and the Company have caused their respective signature page to this
      Securities Purchase Agreement to be duly executed as of the date first written
      above.

     

      
        	 	
                COMPANY:

              
	 	 
	 	
                AGFEED
                  INDUSTRIES, INC.

              
	 	 
	 	
                By:

              	
                /s/
                  Xiong Jun Hong

              
	 	 	
                Name:
                  Xiong
                  Jun Hong

              
	 	 	
                Title:
                  CEO

              

      

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    IN
      WITNESS WHEREOF,
      each
      Buyer and the Company have caused their respective signature page to this
      Securities Purchase Agreement to be duly executed as of the date first written
      above.

     

      
        	 	
                BUYERS:

              
	 	 
	 	
                APOLLO
                  ASIA OPPORTUNITY

                MASTER
                  FUND, L.P.

              
	 	
                By:
                  Apollo Asia Management GP, LLC

              
	 	 
	 	
                By:

              	
                
                  /s/
                    Patricia M. Navis

                

              
	 	 	
                Name:
                  Patricia
                  M. Navis

              
	 	 	
                Title:
                  Vice President

              

      

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    

        
          	 	
                  JABCAP
                    MULTI-STRATEGY MASTER

                  FUND
                    LIMITED

                
	 	
                  J-Invest
                    Ltd

                
	 	 
	 	
                  By:

                	
                  /s/
                    Tse-Ern,
                    Chia

                
	 	 	
                  Name:
                    Tse-Ern,
                    Chia

                
	 	 	
                  Title:
                    Director

                

        

      

      
        
          
          

        

        
          
          

          
            

          

        

        
          
          

        

      

    

    

      
        	 	
                J-
                  INVEST LTD.

              
	 	 
	 	
                By:

              	
                /s/
                  Tse-Ern, Chia

              
	 	 	
                Name:
                  Tse-Ern,
                  Chia

              
	 	 	
                Title:
                  Director

              

      

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

      
        	 	
                DEUTSCHE
                  BANK AG LONDON

              
	 	 
	 	
                By:

              	/s/
                Simon Rani
	 	 	
                Name:
                  Simon
                  Rani

              
	 	 	
                Title:
                  Director

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00137-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00137-of-00352.parquet"}]]